
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5784166
[patent_doc_number] => 20060204441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Cell scaffold matrices with incorporated therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/084350
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23706
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084350
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084350 | Cell scaffold matrices with incorporated therapeutic agents | Mar 17, 2005 | Issued |
Array
(
[id] => 478834
[patent_doc_number] => 07223748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets'
[patent_app_type] => utility
[patent_app_number] => 11/073625
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9159
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223748.pdf
[firstpage_image] =>[orig_patent_app_number] => 11073625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/073625 | Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets | Mar 7, 2005 | Issued |
Array
(
[id] => 326301
[patent_doc_number] => 07514071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Single-use cosmetic article'
[patent_app_type] => utility
[patent_app_number] => 11/074056
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6967
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074056
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074056 | Single-use cosmetic article | Mar 7, 2005 | Issued |
Array
(
[id] => 7046225
[patent_doc_number] => 20050250820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Therapeutic modulation of PPARgamma activity'
[patent_app_type] => utility
[patent_app_number] => 11/075090
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72353
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075090
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075090 | Therapeutic modulation of PPARgamma activity | Mar 6, 2005 | Abandoned |
Array
(
[id] => 252699
[patent_doc_number] => 07579333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Therapy using a combination of raloxifene and alendronate'
[patent_app_type] => utility
[patent_app_number] => 11/062272
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9771
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11062272
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/062272 | Therapy using a combination of raloxifene and alendronate | Feb 17, 2005 | Issued |
Array
(
[id] => 7250526
[patent_doc_number] => 20050142196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Stable pharmaceutical compositions containing an ACE inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/061816
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2774
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11061816
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/061816 | Stable pharmaceutical compositions containing an ACE inhibitor | Feb 17, 2005 | Abandoned |
Array
(
[id] => 7233997
[patent_doc_number] => 20050256149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts'
[patent_app_type] => utility
[patent_app_number] => 11/056968
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5197
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256149.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056968 | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts | Feb 10, 2005 | Abandoned |
Array
(
[id] => 7110534
[patent_doc_number] => 20050207989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'High storage stability inhalable compositions'
[patent_app_type] => utility
[patent_app_number] => 11/054707
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2186
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20050207989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11054707
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/054707 | High storage stability inhalable compositions | Feb 7, 2005 | Issued |
Array
(
[id] => 5672084
[patent_doc_number] => 20060177438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods of altering absorption of hydrophobic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/053553
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11699
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177438.pdf
[firstpage_image] =>[orig_patent_app_number] => 11053553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/053553 | Methods of altering absorption of hydrophobic compounds | Feb 7, 2005 | Abandoned |
Array
(
[id] => 4548182
[patent_doc_number] => 07960370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Type A gelatin capsule containing PUFA in free acid form'
[patent_app_type] => utility
[patent_app_number] => 10/587201
[patent_app_country] => US
[patent_app_date] => 2005-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3864
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587201
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587201 | Type A gelatin capsule containing PUFA in free acid form | Feb 6, 2005 | Issued |
Array
(
[id] => 7098493
[patent_doc_number] => 20050130952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases'
[patent_app_type] => utility
[patent_app_number] => 11/048452
[patent_app_country] => US
[patent_app_date] => 2005-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8723
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11048452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/048452 | Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases | Jan 30, 2005 | Issued |
Array
(
[id] => 5220294
[patent_doc_number] => 20070161605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring'
[patent_app_type] => utility
[patent_app_number] => 10/586822
[patent_app_country] => US
[patent_app_date] => 2005-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17475
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161605.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586822 | Compounds and methods to increase anti-P-glycoprotein activity of baicalein by alkylation on the A ring | Jan 30, 2005 | Issued |
Array
(
[id] => 6223411
[patent_doc_number] => 20100056623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'FUMAGILLOL DERIVATIVES OR METHOD FOR PREPARATION OF FUMAGILLOL DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/814809
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13372
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056623.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814809 | FUMAGILLOL DERIVATIVES OR METHOD FOR PREPARATION OF FUMAGILLOL DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | Jan 25, 2005 | Abandoned |
Array
(
[id] => 418820
[patent_doc_number] => 07276492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Use of ACE inhibitors for treatment of patients suffering from behavioral disorders'
[patent_app_type] => utility
[patent_app_number] => 11/037564
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1814
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037564
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037564 | Use of ACE inhibitors for treatment of patients suffering from behavioral disorders | Jan 17, 2005 | Issued |
Array
(
[id] => 448919
[patent_doc_number] => 07250445
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-31
[patent_title] => 'Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders'
[patent_app_type] => utility
[patent_app_number] => 11/035513
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2803
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035513 | Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders | Jan 13, 2005 | Issued |
Array
(
[id] => 5693763
[patent_doc_number] => 20060153910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins'
[patent_app_type] => utility
[patent_app_number] => 11/041180
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1057
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041180 | Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins | Jan 10, 2005 | Issued |
Array
(
[id] => 6983984
[patent_doc_number] => 20050154054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Stabilized ascorbic acid compositions and methods therefor'
[patent_app_type] => utility
[patent_app_number] => 11/032931
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7258
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20050154054.pdf
[firstpage_image] =>[orig_patent_app_number] => 11032931
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/032931 | Stabilized ascorbic acid compositions and methods therefor | Jan 10, 2005 | Issued |
Array
(
[id] => 587117
[patent_doc_number] => 07435429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-14
[patent_title] => 'Zinc salt compositions for the prevention of dermal and mucosal irritation'
[patent_app_type] => utility
[patent_app_number] => 11/031258
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22769
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/435/07435429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031258 | Zinc salt compositions for the prevention of dermal and mucosal irritation | Jan 6, 2005 | Issued |
Array
(
[id] => 6926552
[patent_doc_number] => 20050239809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Methods for treating and preventing hypertension and hypertension-related disorders'
[patent_app_type] => utility
[patent_app_number] => 11/031477
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23427
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239809.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031477 | Methods for treating and preventing hypertension and hypertension-related disorders | Jan 6, 2005 | Abandoned |
Array
(
[id] => 5380391
[patent_doc_number] => 20090192230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Propofol-containing fat emulsion preparation'
[patent_app_type] => utility
[patent_app_number] => 10/585311
[patent_app_country] => US
[patent_app_date] => 2005-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5247
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585311 | Propofol-containing fat emulsion preparation | Jan 5, 2005 | Abandoned |